Evidence map›Paper›PMID 15026809›Full record

ArticleBritish journal of cancer2004

Fusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool.

H Hashida, M Miyamoto, Y Cho, Y Hida, K Kato, T Kurokawa, S Okushiba, S Kondo, H Dosaka-Akita, H Katoh

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 47 citations in OpenAlex.

  1. HIV-1 Tat: Role in Bystander Toxicity.Frontiers in cellular and infection microbiology · 2020
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy.Molecular therapy : the journal of the American Society of Gene Therapy · 2011
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Vectors for airway gene delivery.The AAPS journal · 2007
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

H HashidaDepartment of Surgical Oncology, Hokkaido University Graduate School of Medicine, N-15, W-7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.
M Miyamoto
Y Cho
Y Hida
K Kato
T Kurokawa
S Okushiba
S Kondo
H Dosaka-Akita
H Katoh
Hokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effective gene therapy depends on the efficient transfer of therapeutic genes to target cells. None of the current technologies, however, satisfy all of the requirements necessary for gene therapy, because the plasma and nuclear membranes of mammalian cells are tight barriers against gene transfer using synthetic delivery systems. The protein transduction domain (PTD) of human immunodeficiency virus type 1 (HIV-1) Tat protein greatly facilitates protein transfer via membrane destabilisation. We synthesised polylysine peptides containing Tat PTD (TAT-pK), or other sequences, and investigated their potential as agents for gene transfer. The synthesised polypeptide TAT-pK retains DNA binding function and mediates delivery of a reporter gene to cultured cells. RGD motif binds with low affinity to alpha integrins which induce cell activation. Two control polypeptides, GGG-pK and RGD-pK, were synthesised and tested, but their gene transfer abilities were weaker than those of TAT-pK. TAT-pK-mediated gene transfer was enhanced in the presence of chloroquine or ammonium chloride, to a greater extent than that of cationic lipid-mediated gene transfer in most cancer cell lines tested. These data suggest that TAT-pK may be a potent candidate delivery vehicle that promotes gene transfer, dependent on the endocytic pathway. We conclude that the TAT-pK/DNA complex is useful as a minimal unit to package therapeutic genes and to transduce them into mammalian cells.

Indexed as

Gene Products, tatGene Transfer TechniquesCarcinomaCarcinoma, Squamous CellCell LineEsophageal NeoplasmsGenes, ReporterGenetic TherapyHumansLung NeoplasmsPancreatic NeoplasmsPeptide FragmentsPolylysineRecombinant Fusion Proteinstat Gene Products, Human Immunodeficiency VirusTumor Cells, CulturedGene Products, tatPeptide FragmentsPolylysineRecombinant Fusion Proteinstat Gene Products, Human Immunodeficiency Virustat peptide (17-25), Human immunodeficiency virus 1

Identifiers

PMID15026809
PMCPMC2409656
OpenAlexW2067390536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.